Free press releases distribution network?

Agency / Source: Gold Biotechnology, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



GoldBio Launches New Product Line - Growth Factors and Stem Cell Reagents - Today in an email to customers, Bart Saracino, Marketing Director, announced the newest line of research products from Gold Biotechnology, Inc.: Growth Factors and Stem Cell Reagents - GoldBio.com
GoldBio Launches New Product Line - Growth Factors and Stem Cell Reagents

 

PRZOOM - /newswire/ - St. Louis, MO, United States, 2013/03/05 - Today in an email to customers, Bart Saracino, Marketing Director, announced the newest line of research products from Gold Biotechnology, Inc.: Growth Factors and Stem Cell Reagents - GoldBio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The Growth Factors and Stem Cell Reagents product line was developed over several months in collaboration with a major university in St. Louis. This move expands the GoldBio product portfolio, allowing the company to move into the area of stem cell research, a field where some of the most important biological processes are mediated. The company anticipates that this will be an area of continued growth for years to come, and that this product line will continue to be expanded throughout the year based on customer insight.

At the time of release, this new line consists of more than 35 widely used human, rat, and murine growth factors. The unique characteristics of the products include their extremely high quality, precise lot-to-lot consistency, and in keeping with the GoldBio brand, affordable price.

With the addition of this new line of products, GoldBio proudly adds its brand to the St. Louis area’s notable history with stem cell research. In the 1950s, Stanley Cohen and Rita Levi-Montalcini isolated nerve growth factor and then discovered epidermal growth factor at Washington University. They jointly received the Nobel Prize in Physiology or Medicine 1986 "for their discoveries of growth factors”. Research on cellular growth factors has proven fundamental to understanding the development of cancer and designing anti-cancer drugs.

About Gold Biotechnology, Inc.

Gold Biotechnology, Inc. was founded in 1986 by Dr. Paul Gold in an effort to provide researchers with high-quality reagents at a low price. A sustainable business model and unique relationships within the supply chain allow GoldBio to provide researchers and scientists with uniquely low prices while maintaining the highest quality in the industry. GoldBio.com now supplies more than 1,000 molecular and cell biology reagents to life and plant science researchers worldwide and has an active molecular biology research and development program.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Gold Biotechnology, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


GoldBio Launches New Product Line - Growth Factors and Stem Cell Reagents

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Bart Saracino - GoldBio.com 
314-890-8778 bart.saracino[.]goldbio.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Gold Biotechnology, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Gold Biotechnology, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  SKS Media | SKS Associates Ltd

Visit  BizJobs.com

Visit  NAKIVO, Inc.







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today